Skip to content

Prescription drug

Sulfinpyrazone (INN)

CAS 57-96-5
8

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

Sulfinpyrazone is a prescription uricosuric drug used to treat gout. It has serious side effects and drug interactions, is not approved for cosmetic use anywhere, and should never appear in skincare products.

Skin benefits

  • Effective prescription medicine for chronic gout by promoting uric acid excretion
  • Has documented antiplatelet activity in clinical use

Known concerns

  • Prescription pharmaceutical, not a cosmetic ingredient
  • Risk of severe gastrointestinal and renal side effects
  • Can cause blood disorders such as aplastic anemia
  • Significant drug interactions with anticoagulants and other medicines
  • Has no legitimate role in skincare or personal care products

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find Sulfinpyrazone (INN) in your products.

Scan any cosmetic product with LuxSense to see if it contains Sulfinpyrazone (INN) and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.